Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction study

Karthik Venkatakrishnan, Michael Rader, Ramesh K. Ramanathan, Suresh Ramalingam, Eric Chen, William Riordan, William Trepicchio, Michael Cooper, Michael Karol, Lisa von Moltke, Rachel Neuwirth, Merrill Egorin, Gurkamal Chatta

Research output: Contribution to journal › Article › peer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction study'. Together they form a unique fingerprint.

Medicine & Life Sciences